Old Web
English
Sign In
Acemap
>
authorDetail
>
Susan E. Wilson
Susan E. Wilson
Novartis
Medicine
Lymphoma
Antibody
Rituximab
Antibody-dependent cell-mediated cytotoxicity
3
Papers
251
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non- Hodgkin's Lymphoma: IL-2 Mediated Natural Killer Cell Expansion Correlations with Clinical Response
2004
Clinical Cancer Research
William Larry Gluck
Deborah Hurst
Alan Yuen
Alexandra M. Levine
Mark A. Dayton
Jon P. Gockerman
Jennifer Lucas
Kimberly Denis-Mize
Barbara Tong
Dawn Navis
Anita Difrancesco
Sandra Milan
Susan E. Wilson
Maurice J. Wolin
Show All
Source
Cite
Save
Citations (151)
Conversion of antibody-resistant cancer patients to antibody-sensitive: Investigation of Fc receptor polymorphisms and response to IL-2 and rituximab treatment in rituximab-refractory NHL patients
2004
Journal of Clinical Oncology
Charles F. Eisenbeis
John P. Leonard
J. Rosenblatt
K. D. Khan
Pierluigi Porcu
Sandra Milan
Susan E. Wilson
Deborah Hurst
Michael A. Caligiuri
Lawrence Piro
Show All
Source
Cite
Save
Citations (3)
1